Screening strategy for de novo donor‐specific HLA antibodies beyond the first year after kidney transplantation: Personalized or “one size fits all”?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Screening strategy for de novo donor‐specific HLA antibodies beyond the first year after kidney transplantation: Personalized or “one size fits all”?

Published:2020-12-12 Issue:2 Volume:35 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Cun Hasret¹,Hönger Gideon¹²³,Kleiser Marc³,Amico Patrizia¹³,Wehmeier Caroline¹^ORCID,Steiger Jürg¹²,Dickenmann Michael¹,Schaub Stefan¹²³^ORCID

Affiliation:

1. Clinic for Transplantation Immunology and Nephrology University Hospital Basel Basel Switzerland

2. Transplantation Immunology Department of Biomedicine University of Basel Basel Switzerland

3. HLA‐Diagnostic and Immungenetics Department of Laboratory Medicine University Hospital Basel Basel Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ctr.14170

Reference40 articles.

1. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence

2. Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant

3. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials

4. Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

5. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of Routine Post Kidney Transplant Anti-HLA Antibody Screening;Kidney International Reports;2024-05

2. A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression;AM J TRANSPLANT;2023

3. A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression;American Journal of Transplantation;2023-12

4. CXCR5+CD8+ T Cell–Mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition;Transplantation;2023-10-24

5. The natural history of de novo donor-specific HLA antibodies after kidney transplantation;Frontiers in Medicine;2022-09-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3